October 31, 2019

MADISON, WI, USA, Oct 31, 2019 – Invenra Inc. announced that it has expanded its collaboration with Exelixis, Inc. (Nasdaq: EXEL). Exelixis and Invenra had entered into a collaboration on May 2nd, 2018 to discover and develop multispecific antibodies...

January 31, 2019

Madison, WI.  Jan 31, 2019 – Invenra and WARF (Wisconsin Alumni Research Foundation) today announced they have entered into a collaboration to discover and develop a bispecific antibody therapeutic for the treatment of neuroblastoma, a cancer that is...

October 17, 2018

MADISON, Wis. – October 17, 2018 – Invenra, an antibody drug discovery and development company with novel multispecific platforms and product candidates, announced the close of a $7M Series B financing round. The financing will be used to expand the...

May 2, 2018

̶ Companies will partner to advance multispecific antibodies in up to seven discrete projects, including one program against an undisclosed target currently in lead selection –

̶ Exelixis’ expansion into biologics builds upon history of success in the...

September 26, 2017

MADISON, WI – September 26, 2017 – Invenra is pleased to announce the addition of Dr. Paul Sondel in the role of Chief Medical Advisor (Volunteer). Dr. Paul Sondel [MD- Harvard Medical School, and PhD in Genetics– University of Wisconsin-Madison (UW)...

Please reload

PRESS RELEASES

Invenra Announces Expansion of Collaboration with Exelixis

October 31, 2019

1/1
Please reload

Featured
Please reload

Archive
 

CONFERENCE ATTENDANCE

 

Bispecific Antibody Pipeline Congress

08.20.2019

Washington DC

Bonnie Hammer, Vice President - Research and Development, is a guest speaker.

World Bispecific Antibody Summit

09.17.2019

Waltham, MA

Advances in Immuno-Oncology USA Congress

10.08.2019

San Diego, CA

Bryan Glaser, Vice President - Business Development, is a guest speaker.

Festival of Biologics 2019

10.15.2019

Basel, Switzerland

SITC 2019

11.06.2019

National Harbor, Maryland

PEGS Europe

11.18.2019

Lisbon, Portugal

Mandar Bawadekar, Senior Scientist - Immunology, is a guest speaker.

Antibody Engineering & Therapeutics

12.09.2019

San Diego, CA

Dileep Pulukkunat, Group Leader, is a guest speaker.

Please reload

Invenra®

505 South Rosa Road; Suite 235, Madison, WI 53719       info@invenra.com  |   608.441.8319

connect with us
  • Twitter - Black Circle
  • LinkedIn - Black Circle

© 2018 Invenra, Inc. All Rights Reserved.